Particle.news
Download on the App Store

Inspire Medical Hit With Securities Class Action Over Inspire V Launch as Firms Court Lead Plaintiffs

Investors who purchased INSP during the alleged class period have until January 5, 2026 to seek lead-plaintiff appointment.

Overview

  • The case, City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., No. 25-cv-04247, is pending in the U.S. District Court for the District of Minnesota.
  • Plaintiffs allege Inspire and certain executives misled investors about demand for the Inspire V device and the company's readiness to roll it out.
  • The complaint cites operational breakdowns including incomplete center training and onboarding, insurer claims software not updating until July 1, and gaps in Medicare and billing readiness, along with surplus inventory depressing demand.
  • On August 4, 2025, the company disclosed delays in the Inspire V rollout and cut 2025 EPS guidance by more than 80%, after which the stock fell over 32%, or $42.04 per share, erasing roughly $1.2 billion in market value.
  • Robbins Geller Rudman & Dowd, Bronstein Gewirtz & Grossman, and Robbins LLP are soliciting class members for lead-plaintiff roles, while the Schall Law Firm announced a parallel investor investigation.